Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,201–1,300 of 3,349
Werner, C. T., Williams, C. J., Fermelia, M. R., Lin, D., & Li, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01174 · Cited by 34
West Nile Virus-Induced Neurologic Sequelae—Relationship to Neurodegenerative Cascades and Dementias
Vittor, A. Y., Long, M. T., Chakrabarty, P., Aycock, L., Kollu, V., & DeKosky, S. T. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00200-7 · Cited by 36
Laursen, N. S., Pedersen, D. V., Gytz, H., Zarantonello, A., Jensen, J. M. B., Hansen, A. G., Thiel, S., & Andersen, G. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01504 · Cited by 33
“However, the same pathway that ensures correct development by pruning excess synapses, seems to be involved in neurodegenerative conditions like AD (62).”
BackgroundInfluentialPDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity
Rombaut, B., Kessels, S., Schepers, M., Tiane, A., Paes, D., Solomina, Y., Piccart, E., van den Hove, D., Brône, B., Prickaerts, J., et al. (2020) · Theranostics · doi:10.7150/thno.50701 · Cited by 35
“However, synaptic elimination might be turned back on aberrantly in the aged and diseased brain [118].”
BackgroundXue, F., Tian, J., Yu, C., Du, H., & Guo, L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105272 · Cited by 32
Jin, S., Wang, X., Xiang, X., Wu, Y., Hu, J., Li, Y., Dong, Y. L., Tan, Y., & Wu, X. G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108335 · Cited by 37
Gao, Z., Zhang, C., Feng, Z., Liu, Z., Yang, Y., Yang, K., Chen, L., & Yao, R. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113947 · Cited by 34
Allison, R. L., Welby, E., Khayrullina, G., Burnett, B. G., & Ebert, A. D. (2022) · Glia · doi:10.1002/glia.24153 · Cited by 32
Li, S., Chen, Y., Zhang, Y., Lv, H., Luo, L., Wang, S., & Guan, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02079 · Cited by 35
Self-citationActivity-dependent modulation of hippocampal synaptic plasticity via PirB and endocannabinoids
Djurisic, M. R., Brott, B. K., Saw, N. L., Shamloo, M., & Shatz, C. J. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0034-4 · Cited by 37
“Also located in the MHC locus are components of the complement cascade, some of which are also expressed in neurons [4, 10].”
Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging
Sadasivam, P., Fang, X. T., Toyonaga, T., Lee, S., Xu, Y., Zheng, M.-Q., Spurrier, J., Huang, Y., Strittmatter, S. M., Carson, R. E., et al. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01567-9 · Cited by 31
The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease
Qureshi, Y. H., Berman, D. E., Marsh, S. E., Klein, R. L., Patel, V. M., Simoes, S., Kannan, S., Petsko, G. A., Stevens, B., & Small, S. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110262 · Cited by 31
Self-citationYan, Y., Aierken, A., Wang, C., Song, D. F., Ni, J., Wang, Z., Quan, Z., & Qing, H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.009 · Cited by 33
Jung, H., Lee, H., Kim, D., Cheong, E., Hyun, Y., Yu, J., & Um, J. W. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s362006 · Cited by 40
Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein
Stoner, A. J., Fu, L., Nicholson, L., Zheng, C., Toyonaga, T., Spurrier, J. M., Laird, W., Cai, Z., & Strittmatter, S. M. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01345-z · Cited by 37
“…impact plaque burden or Aβ staining, PrP C contributes to the formation of PrP C is required for the localization of C1q to PSD‑95 puncta Microglia-mediated phagocytosis of synapses is mediated by C1q and is implicated in AD synapse loss with complement tagging synapses for removal [19, 47, 48].”
BackgroundMhm, N., Chakravarthi, S., Aung, T., Htoo, P. M., Shwe, W. H., Gupalo, S., Udayah, M. W., Singh, H., Kabir, M. S., Thangarajan, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157212 · Cited by 41
“In LPS exposure models, microglia with increased PI3K signaling are seen to engulf increased amounts of synaptic debris, which decreases spine density in the hippocampus and prefrontal cortex [89].”
Jiang, S., & Bhaskar, K. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161123 · Cited by 30
“Notably, knocking out C1q/C3 or neutralizing the C1q with a C1q-specific antibody ANX-M1 in non-transgenic mice injected with oligomeric Aβ blocked excessive pruning of synapses by microglia and prevented synaptic loss [9, 38, 40].”
InfluentialAutophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 35
Zhao, Y., Luo, C., Chen, J., Sun, Y., Pu, D., Lv, A., Zhu, S., Wu, J., Wang, M., Zhou, J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13884 · Cited by 37
“In the mice model of Alzheimer's disease, elevated localization of C3 onto hippocampal synapses resulted in synapse loss caused by amyloid‐β.(18) In addition,”
BackgroundResultOlsen, I., & Singhrao, S. K. (2020) · Journal of Oral Microbiology · doi:10.1080/20002297.2020.1820834 · Cited by 44
“This can lead to their aberrant digestion of nerve synapses [39].”
BackgroundPrecision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics
Gavriilaki, M., Kimiskidis, V. Κ., & Gavriilaki, E. (2020) · Pharmaceuticals · doi:10.3390/ph13110341 · Cited by 33
“Antibody against C1q proved to efficiently prevent synapse loss in an AD animal model and has been successfully tested in a clinical trial (NCT03010046) for safety and tolerability in healthy volunteers [22,131].”
BackgroundResultAn Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models
Spanos, F., & Liddelow, S. A. (2020) · Cells · doi:10.3390/cells9112415 · Cited by 35
Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits
Meri, S., & Haapasalo, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611830 · Cited by 34
“Interestingly, the classical pathway of complement with its components C1q and C4 appear to contribute to the complement- and microgliamediated loss of brain synapses in early Alzheimer’s disease (36).”
BackgroundCardoso, F. D. S., Mansur, F., Araújo, B. H. S., Gonzalez-Lima, F., & da Silva, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02606-4 · Cited by 37
“This process is directly involved with cellular dysfunctions characteristic of aging and Alzheimer’s disease [35, 36], which may result in an increase in the activation of signaling pathways linked to inflammation and cellular death such as c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38) […”
BackgroundShinjyo, N., Kagaya, W., & Pekna, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.710390 · Cited by 34
Feng, B., Freitas, A. E., Gorodetski, L., Wang, J., Tian, R., Lee, Y. R., Grewal, A. S., & Zou, Y. (2021) · Science Advances · doi:10.1126/sciadv.abh2307 · Cited by 43
“Astrogliosis and microglia activation are observed in the 5XFAD mice and other A models (27, 31).”
BackgroundMoreira, A. P., Vizuete, A. F. K., Zin, L. E. F., Marques, C. D. O., Pacheco, R. F., Leal, M. B., & Gonçalves, C. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00476-9 · Cited by 33
Cooze, B., Dickerson, M., Loganathan, R., Watkins, L. M., Grounds, E., Pearson, B., Bevan, R. J., Morgan, B. P., Magliozzi, R., Reynolds, R., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13054 · Cited by 36
“Synaptic and neuritic degeneration is one underlying cause of tissue volume loss and synaptic pruning is driven by complement C3 mediated opsonisation and uptake by complement receptorbearing microglia [28].”
BackgroundWu, X., Ji, M., Yin, X., Gu, H., Zhu, T., Wang, R.-Z., Yang, J., & Shen, J.-C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108724 · Cited by 33
Dong, Q., Li, Z., Zhang, Q., Hu, Y., Liang, H., & Xiong, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924429 · Cited by 36
“…such as anti-inflammatory, antioxidant, immunomodulating properties, which entitle this group of compounds with therapeutic effects on neurodegenerative diseases, particularly AD (Liu Z et al., 2014; Zhao and Dong, 2016; Huang et al., 2017; Qin et al., 2020; Liu X et al., 2021), as shown inTable 3.”
BackgroundIshihara, Y., Honda, T., Ishihara, N., Namba, K., Taketoshi, M., Tominaga, Y., Tsuji, M., Vogel, C. F. A., Yamazaki, T., Itoh, K., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02559-y · Cited by 34
“Microglia are immune cells in the central nervous system that play important roles in brain pathologies such as Alzheimer’s disease and epilepsy [11, 12].”
BackgroundThe X factor in neurodegeneration
Voskuhl, R. R., & Itoh, Y. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211488 · Cited by 38
Lan, G., Li, A., Liu, Z., Ma, S., Guo, T., & Initiative, A. D. N. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12890 · Cited by 32
Yang, Y., García-Cruzado, M., Zeng, H., Camprubí-Ferrer, L., Bahatyrevich-Kharitonik, B., Bachiller, S., & Deierborg, T. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.006 · Cited by 33
“In the RSC region, we observed a decrease in colocalization of pre-synapses (Synaptophysin) and post-synapses (PSD95) in RSC (Fig.”
BackgroundMethodInfluentialMicroglia‐targeted stem cell therapies for Alzheimer disease: A preclinical data review
Shen, Z., Li, X., Bao, X., & Wang, R. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24066 · Cited by 35
“However, a recent study in Science shows that microglia in early AD brains engulf synaptic material in a complement-dependent process resulting in synapse loss (Hong et al., 2016).”
BackgroundThe Pathological Activation of Microglia Is Modulated by Sexually Dimorphic Pathways
O'Connor, J. L., & Nissen, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054739 · Cited by 36
Zhou, A., Cheng, H., Liu, H., Li, L., Chen, Z., Chen, S., Wang, C., & Wang, D. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121033 · Cited by 32
Λεάνδρου, Ε., Chalatsa, I., Anagnostou, D., Machalia, C., Semitekolou, M., Filippa, V., Makridakis, M., Vlahou, A., Anastasiadou, E., Vekrellis, K., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00401-4 · Cited by 36
“Even though neuronal C1q and C3 are normally downregulated in the adult CNS, the complement-dependent synaptic removal is thought to be aberrantly activated in Alzheimer’s disease by Aβ oligomers, thereby contributing to early synaptic loss [37].”
BackgroundChen, Y., Chu, J. M. T., Wong, G. T. C., & Chang, R. C. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10107-z · Cited by 40
“C3 is the central molecule of the complement cascade and is involved in synaptic elimination by mediating microglial phagocytic activity via the CR3 or C3aR pathways (Hong et al. 2016; Vasek et al. 2016; Litvinchuk et al. 2018; Werneburg et al. 2020).”
BackgroundGlial polarization in neurological diseases: Molecular mechanisms and therapeutic opportunities
Liu, Y., Wu, L., Peng, W., & Mao, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102638 · Cited by 36
Dobryakova, Y. V., Kasianov, A. S., Zaichenko, M. I., Stepanichev, M. Y., Chesnokova, E., Kolosov, P. M., Markevich, V. A., & Bolshakov, A. P. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00429 · Cited by 31
Caspases orchestrate microglia instrumental functions
Shen, X., Venero, J. L., Joseph, B., & Burguillos, M. Á. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.007 · Cited by 32
The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer’s Disease
Ziegler-Waldkirch, S., & Meyer-Luehmann, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00473 · Cited by 21
Regional Molecular Mapping of Primate Synapses during Normal Healthy Aging
Graham, L. C., Naldrett, M. J., Kohama, S. G., Smith, C., Lamont, D. J., McColl, B. W., Gillingwater, T. H., Skehel, P., Urbanski, H. F., & Wishart, T. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.096 · Cited by 31
Chunchai, T., Keawtep, P., Arinno, A., Saiyasit, N., Prus, D., Apaijai, N., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2019) · Aging · doi:10.18632/aging.101989 · Cited by 31
“For example: 1) Microglia excessively prune synapses and increase pro-inflammatory cytokines in models of Alzheimer's disease [23, 24].”
BackgroundMicroglia: sculptors of neuropathic pain?
Ward, H. L., & West, S. J. (2020) · Royal Society Open Science · doi:10.1098/rsos.200260 · Cited by 38
la Fuente-Muñoz, C. E. D., Rosas‐Lemus, M., Moreno‐Castilla, P., Bermúdez‐Rattoni, F., Uribe‐Carvajal, S., & Arias, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228727 · Cited by 36
“Thus, to shed light on whether there is a relationship between aging and AD in mitochondrial synaptic dysfunction, we conducted experiments in isolated presynaptic terminals from three brain regions implicated in AD pathology from female 3xTg-AD mice and female wild-type (WT) mice at young and middle age, at which the…”
BackgroundMethodMicroglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis
Bagheri‐Mohammadi, S. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03162-4 · Cited by 31
Westacott, L. J., Humby, T., Haan, N., Brain, S. A., Bush, E., Toneva, M., Baloc, A.-I., Moon, A. L., Reddaway, J., Owen, M. J., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.005 · Cited by 32
The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer’s Disease
Qin, Q., Wang, M., Yin, Y., & Tang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845897 · Cited by 42
“examined a mouse model of Alzheimer’s disease and showed that C1q was significantly increased before significant plaque deposition and was associated with synapse clearance (65).”
BackgroundPrevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s disease
Kater, M. S. J., Huffels, C. F. M., Oshima, T., Renckens, N. S., Middeldorp, J., Boddeke, E., Smit, A. B., Eggen, B. J. L., Hol, E. M., & Verheijen, M. H. G. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.009 · Cited by 32
Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 34
Medusa's Head: The Complement System in Traumatic Brain and Spinal Cord Injury
Roselli, F., Karasu, E., Volpe, C., & Huber-Lang, M. S. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5168 · Cited by 32
“76,77 The extent of complement-mediated synaptic loss in TBI and how much this may contribute to the onset of acute deficits remain to be further investigated.”
Opposing Roles of apolipoprotein E in aging and neurodegeneration
Hudry, E., Klickstein, J., Cannavo, C., Jackson, R., Muzikansky, A., Gandhi, S., Urick, D., Sargent, T., Wrobleski, L., Roe, A. D., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900325 · Cited by 30
“…effects of amyloid deposition that may participate in network deterioration (Pozueta et al, 2013; Spires et al, 2005; Spires-Jones & Hyman, 2014; Hong et al, 2016; Arbel-Ornath et al, 2017) and considering that we detected a change in the aggregation state of amyloid deposits in the cortex of…”
BackgroundIsacson, O., Brekk, O. R., & Hallett, P. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01053 · Cited by 32
“C1q is implicated as an early mediator of neuronal dysfunction in preclinical models of AD, whereby reduced expression or blockade of C1q rescues synaptic loss and dysfunction upon exposure to toxic amyloid-beta (60); similarly, C1qa knockdown mitigates neurotoxicity in an in vivo model of frontotemporal dementia (61).”
BackgroundSt-Pierre, M.-K., Carrier, M., Lau, V., & Tremblay, M.-È. (2022) · Methods in Molecular Biology · doi:10.1007/978-1-0716-2409-8_3 · Cited by 29
Wang, G., Liu, H., Meng, X., Chen, Y., Zhao, W., Li, W., Xu, H., Peng, K., & Ji, F. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01223-7 · Cited by 32
The role of integrins in brain health and neurodegenerative diseases
Cui, Y., Rõlova, T., & Fagerholm, S. C. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151441 · Cited by 36
Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy
McGeachan, R. I., Keavey, L., Simzer, E. M., Chang, Y. Y., Rose, J. L., Spires-Jones, M. P., Gilmore, M., Holt, K., Meftah, S., Ravingerova, N., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01992-5 · Cited by 44
“This is of particular interest given the known role complement has in mediating synaptic pruning 25,45 .”
Ma, X., Wang, Y., Hua, J., Xu, C., Yang, T., Yuan, J., Chen, G., Guo, Z., & Wang, X. (2019) · Science China Chemistry · doi:10.1007/s11426-019-9594-y · Cited by 30
Epigenetic Signaling in Glia Controls Presynaptic Homeostatic Plasticity
Wang, T., Morency, D. T., Harris, N., & Davis, G. W. (2019) · Neuron · doi:10.1016/j.neuron.2019.10.041 · Cited by 27
Li, A., Zhao, J., Fan, C., Zhu, L., Huang, C., Li, Q., Gan, D., Wen, C., Chen, M., & Lu, D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.012 · Cited by 32
The Impact of Complement Genes on the Risk of Late-Onset Alzheimer’s Disease
Carpanini, S. M., Harwood, J. C., Baker, E. A., Torvell, M., Sims, R., Williams, J. H., & Morgan, B. P. (2021) · Genes · doi:10.3390/genes12030443 · Cited by 30
“In AD mouse models, back-crossing to complement deficiencies has supported the critical role of complements in neuroinflammation and synapse loss [30,33].”
BackgroundScabia, G., Testa, G., Scali, M., Turco, S. D., Desiato, G., Berardi, N., Sale, A., Matteoli, M., Maffei, L., Maffei, M., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.222 · Cited by 31
Gruber, V., Luinenburg, M. J., Colleselli, K., Endmayr, V., Anink, J. J., Zimmer, T. S., Jansen, F. E., Gosselaar, P. H., Coras, R., Scholl, T. O., et al. (2021) · Epilepsia · doi:10.1111/epi.17139 · Cited by 30
“Autopsy & biopsy 27 16:11 15 (11) — — —”
BackgroundTakata, K., Kimura, H., Yanagisawa, D., Harada, K., Nishimura, K., Kitamura, Y., Shimohama, S., & Tooyama, I. (2022) · Molecules · doi:10.3390/molecules27092780 · Cited by 31
Li, Y., Chen, Z., Wang, Q., Lv, X., Cheng, Z., Wu, Y., Tang, F., Shen, Y., & Gao, F. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11476-2 · Cited by 27
“Previous studies have also found that microglia-mediated synaptic phagocytosis in mouse models may be abnormally activated in AD and explained the cause of early synaptic loss in the brain [51].”
BackgroundWang, R., Liu, Z., Bi, N., Gu, X., Huang, C., Zhou, R., Liu, H., & Wang, H.-L. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115034 · Cited by 33
Zhang, W., Ding, L., Zhang, M., Zheng, S., Ma, R., Gong, J., Mao, H., Xu, H., Xu, P., & Zhang, Y. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04807-7 · Cited by 36
“As the initiating protein of the classical complement cascade, C1q is thought to be neurotoxic and contributes to neuronal death and synapse loss in neurodegenerative diseases and neurological disorders [34, 43, 44].”
BackgroundGenetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease
Nott, A., & Holtman, I. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168539 · Cited by 36
Reactive astrocytes associated with prion disease impair the blood brain barrier
Kushwaha, R., Li, Y., Makarava, N., Pandit, N. P., Molesworth, K., Birukov, K. G., & Baskakov, I. V. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106264 · Cited by 34
“…protective to highly toxic with respect to their effect on neuronal survival, have been described in different neurodegenerative diseases, disease stages, and animal models (Hong et al., 2016; Chung et al., 2013; Yun et al., 2018; Liddelow et al., 2017; Kushwaha et al., 2021; Zhu et al., 2016).”
Yang, J., Yuan, S., Jian, Y., Lei, Y., Hu, Z., Yang, Q., Yan, X., Zheng, L., Li, J.-H., & Liu, W. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122042 · Cited by 39
Daniels, M. J. D., Lefèvre, L., Szymkowiak, S., Drake, A., McCulloch, L. J., Tzioras, M., Barrington, J., Dando, O., He, X., Mohammad, M., et al. (2023) · eLife · doi:10.7554/elife.85279 · Cited by 32
“However, we cannot confirm whether this apparent synapse loss is a result of increased microglial uptake ( Hong et al., 2016 ) or direct synaptotoxicity ( Tzioras et al., 2023b ).”
Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
Liu, Y., Chen, W.-T., Lin, Y.-Y., Lu, P.-H., Hsieh, S.-L. E., & Cheng, I. H.-J. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0173-0 · Cited by 30
“In the pre-plaque AD mouse oAβ and complement C1q initiate complement cascade and recruit microglia via CR3 to eliminate synapses [40].”
Microglia Mediate Synaptic Material Clearance at the Early Stage of Rats With Retinitis Pigmentosa
He, J., Zhao, C., Dai, J., Weng, C. H., Bian, B., Gong, Y. L., Ge, L., Fang, Y., Liu, H., Xu, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00912 · Cited by 32
“The process morphology was scored as 0 (>15 thick processes with multiple branches), 1 (5–15 thick processes with branches), 2 (1–5 thick processes with few branches), and 3 (no clear processes), using a previously described protocol (12, 28).”
BackgroundMethodResultInfluentialHeuer, S. E., Neuner, S. M., Hadad, N., O'Connell, K. M. S., Williams, R. W., Philip, V. M., Gaiteri, C., & Kaczorowski, C. C. (2020) · Learning & Memory · doi:10.1101/lm.051839.120 · Cited by 29
Davé, V. A., & Klein, R. S. (2023) · Glia · doi:10.1002/glia.24294 · Cited by 29
“…© 2022 Wiley Periodicals LLC. 803 sleep and aging (Clark et al., 2021; Datta et al., 2020; Shi et al., 2015; Stephan et al., 2013; Wang, Yue, et al., 2020), and increase in diseases with cognitive deficits (Hong et al., 2016; Michailidou et al., 2015; Vasek et al., 2016).”
BackgroundWu, Y., Zhang, Y., Yu, Y., Wang, X., Zhen, Z., Yuan, Y., Xie, B., Han, M., Wang, M., Zhang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62181-3 · Cited by 29
“For instance, in Alzheimer ’ s disease, both C1q and C3 are involved in microglia-mediated synaptic loss 34 , while excessive complement C4 activity is associated with reduced synapsenumbersinschizophrenia 35 .”
Gabrielli, M., Tozzi, F., Verderio, C., & Origlia, N. (2022) · Cells · doi:10.3390/cells12010063 · Cited by 36
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
Juul‐Madsen, K., Parbo, P., Ismail, R., Ovesen, P. L., Schmidt, V., Madsen, L. S., Thyrsted, J., Gierl, S., Breum, M., Larsen, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45627-y · Cited by 36
“Genetic ablation of CR3 itself increased the formation of A β deposits 27,28 .”
BackgroundThe activation of microglia by the complement system in neurodegenerative diseases
Zhao, H., Lv, Y., Xu, J., Song, X., Wang, Q., Zhai, X., Ma, X., Qiu, J., Cui, L., & Sun, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102636 · Cited by 34
Convergence of sepsis-associated encephalopathy pathogenesis onto microglia
Xiao, D., Wang, X., Liang, W., Yang, Y., Du, Y., Liu, C., Xu, F., Yang, Y., Wei, M., & Yang, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06635-8 · Cited by 36
“The complement system activated during neuroinflammation promotes the phagocytic activity of microglia, resulting in inappropriate pruning of synapses [180, 181].”
Repeated head trauma causes neuron loss and inflammation in young athletes
Butler, M. L. M. D., Pervaiz, N., Breen, K., Calderazzo, S. M., Ypsilantis, P., Wang, Y., Breda, J. C., Mazzilli, S. A., Nicks, R., Spurlock, E., et al. (2025) · Nature · doi:10.1038/s41586-025-09534-6 · Cited by 61
“RHIM2 expressed C1QA , C1QB , C1QC and CAMK2D , which encode the components and downstream effector of the C1q complement cascade that is known to drive aberrant synaptic engulfment in the neurodegenerative brain 22 (Fig.”
Dual functions of microglia in the formation and refinement of neural circuits during development
Konishi, H., Kiyama, H., & Ueno, M. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.09.009 · Cited by 35
“The retinogeniculate system, which elicits neuronal activity-dependent synaptic refinement during postnatal development (Hooks and Chen, 2006), demonstrated impaired synaptic pruning in mice deficient for C1q, C3, C4 (which pro- motes C3 activation), or microglial CR3 (Stevens et al., 2007;…”
BackgroundNeuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
“In both an APP/PS1 murine model, as well as in a stress‐induced depression paradigm, inhibition of C3 prevented synapse loss, the onset of cognitive impairments, monocyte infiltration, and neuroinflammation (Crider et al., 2018; Hong et al., 2016).”
BackgroundNeuro-regeneration Therapeutic for Alzheimer’s Dementia: Perspectives on Neurotrophic Activity
Sun, M., & Alkon, D. L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.008 · Cited by 31
Wu, J., Bie, B., Foss, J. F., & Naguib, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01885-7 · Cited by 31
“[3, 10, 14], we hypothesized that amyloid fibrils induce down-”
Ramdhani, S., Navarro, E., Udine, E., Efthymiou, A. G., Schilder, B. M., Parks, M., Goate, A., & Raj, T. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008549 · Cited by 28
“Indeed, C1q and oligomeric forms of amyloid-β operate in a common pathway to activate the complement cascade and drive synapse elimination by microglia [49].”
BackgroundThe age-related microglial transformation in Alzheimer's disease pathogenesis
Yuan, C., Aierken, A., Xie, Z., Li, N., Zhao, J., & Qing, H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.024 · Cited by 28
Pedersen, H., Jensen, R. K., Hansen, A. G., Gadeberg, T. A. F., Thiel, S., Laursen, N. S., & Andersen, G. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012339 · Cited by 28
“Furthermore, complement activation has also been linked to multiple neurological diseases, including schizophrenia (16) and early stages of Alzheimer’s disease (17).”
BackgroundThe Role of Synaptic Dysfunction in Alzheimer’s Disease
Pei, Y. A., Davies, J., Zhang, M., & Zhang, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191334 · Cited by 32
“However, overactivity of microglia can lead to chronic neuroinflammation in the brain [72].”
Liang, Y., Raven, F., Ward, J. F., Zhen, S. Y., Zhang, S., Sun, H., Miller, S., Choi, S. H., Tanzi, R. E., & Zhang, C. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200128 · Cited by 32
Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases
Edison, P. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.017 · Cited by 29
Kilinc, D., Vreulx, A.-C., Mendes, T., Flaig, A., Coelho, D. M., Verschoore, M., Demiautte, F., Amouyel, P., Bank, N.-C. B., Eysert, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa139 · Cited by 38
“activation (Hong et al., 2016); and (iii) direct interaction”
Detection of Synaptic Proteins in Microglia by Flow Cytometry
Brioschi, S., d’Errico, P., Amann, L. S., Janova, H., Wojcik, S. M., Meyer-Luehmann, M., Rajendran, L., Wieghofer, P., Paolicelli, R. C., & Biber, K. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00149 · Cited by 28
Fields, J. A., Swinton, M. K., Montilla‐Perez, P., Ricciardelli, E., & Telese, F. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0128 · Cited by 30
“2,18 24–28 Astrocytes also express TFs that suppress in-flammatory transcriptional responses such as peroxisome proliferator-activated receptors (PPAR) a and c , which are implicated in neuroprotective mechanisms, 29–32 or members of the SMAD family of TFs, which are known mediators of the…”
O’Connell, K. S., Sønderby, I. E., Frei, O., van der Meer, D., Athanasiu, L., Smeland, O. B., Alnæs, D., Kaufmann, T., Westlye, L. T., Steen, V. M., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721000179 · Cited by 30
Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?
Nitsch, L., Schneider, L. H., Zimmermann, J., & Müller, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.639353 · Cited by 31
Carlström, E. L., Niazi, A., Etemadikhah, M., Halvardson, J., Enroth, S., Stockmeier, C. A., Rajkowska, G., Nilsson, B., & Feuk, L. (2021) · Genes · doi:10.3390/genes12081242 · Cited by 35
“There are other disorders that are associated with increased complement activation in the brain, including Alzheimer's disease [36,37], Parkinson’s disease [38] and stroke [39].”
BackgroundYang, Y., Seok, M., Kim, Y. E., Choi, Y., Song, J., Sulistio, Y. A., Kim, S., Chang, M., Oh, S., Nam, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01693-6 · Cited by 32
“The complement cascade is inappropriately activated and mediates synapse loss in AD; thus, deletion or blocking of C3 and C1q, the major components of the complement cascade, rescues synaptic and memory losses in AD [77, 78].”
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.